Cytokinetics Incorporated (CYTK)’s Financial Results Comparing With Intec Pharma Ltd. (NASDAQ:NTEC) | Financial Headlines

We are comparing Cytokinetics Incorporated (NASDAQ:CYTK) and Intec Pharma Ltd. (NASDAQ:NTEC) on their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. They both are Biotechnology companies, competing one another.

Valuation Earnings

Table 1 highlights Cytokinetics Incorporated and Intec Pharma Ltd.’s top-line revenue, earnings per share and valuation.

Profitability

Table 2 hightlights the return on equity, net margins and return on assets of the two companies.

Analyst Recommendations

The table delivered features the ratings and recommendations for Cytokinetics Incorporated and Intec Pharma Ltd.

Cytokinetics Incorporated’s upside potential is 77.51% at a $15 average price target.

Institutional Insider Ownership

The shares of both Cytokinetics Incorporated and Intec Pharma Ltd. are owned by institutional investors at 73.6% and 39.64% respectively. Cytokinetics Incorporated’s share held by insiders are 0.4%. Competitively, insiders own roughly 11.81% of Intec Pharma Ltd.’s

... read more at: https://finheadlines.com/2019/04/16/cytokinetics-incorporated-cytks-financial-results-comparing-with-intec-pharma-ltd-nasdaqntec/

by

Leave a Reply